Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 676 AL 690

Phenotypic Spectrum and Clinical Approach to Early-Onset Hereditary Spastic Paraplegia

Wilson JL, Blackstone C, Ebrahimi-Fakhari D, França Junior MC.

Mov Disord Clin Pract. 2026 Sep 20:10.1002/mdc3.70827. doi: 10.1002/mdc3.70827. Online ahead of print.

Dystonia in Parkinson's disease: Clinical characteristics and predictors of treatment response

Yu Z, de la Esperanza BT, Abanto J, Deraz H, Duque KR, Marsili L, Hill EJ, Dwivedi AK, Espay AJ, Mahajan A.

Parkinsonism Relat Disord. 2026 Sep;150:108422. doi: 10.1016/j.parkreldis.2026.108422. Epub 2026 Jul 9.

Glutaric aciduria type 1 presenting with Parkinsonism with presynaptic dopaminergic dysfunction in an adult female: a case report

Lokar M, Georgiev KJ, Rus T, Gregorič N, Peterlin B, Pušenjak MŠ, Georgiev D.

Neurogenetics. 2026 Sep 15;27(1):70. doi: 10.1007/s10048-026-00940-0.

Disorders of the Basal Ganglia and Cerebellum: A Comprehensive Review of Speech Sensorimotor Symptoms and Responses to Feedback Perturbations

Wang H, Max L.

Neurobiol Lang (Camb). 2026 Sep 14;7:NOL.a.291. doi: 10.1162/NOL.a.291. eCollection 2026.

Spectrum of Dystonia in Progressive Supranuclear Palsy: A Prospective Observational Study and Review of Literature

Gulati K, Pandey S.

Tremor Other Hyperkinet Mov (N Y). 2026 Aug 19;16:48. doi: 10.5334/tohm.1243. eCollection 2026.

Brain O-GlcNAcylation in Neurodegenerative Diseases: Context-Dependent Mechanisms and Precision Therapeutic Translation

Lu S, Chen Z, Wang Y, Bian H, Yu S, Huang L.

Brain Sci. 2026 Aug 4;16(8):828. doi: 10.3390/brainsci16080828.

Neuroprotective Effect of Morin Against Chemical-Induced Neurotoxicities and Neurodegenerative Disease Models

Ekundayo BE, Ekundayo MC, Alonge SA, Obafemi BA, Obafemi TO, Lebelo SL, Ntwasa MM.

Eur J Neurosci. 2026 Sep;64(6):e70692. doi: 10.1111/ejn.70692.

Engram cell vulnerability in neurodegeneration: from mechanistic insights to therapeutic horizons

Bai Q, Yan Y, Zeng C, Li X, Zeng G, Saidova A, Li H, Qing H.

Front Aging Neurosci. 2026 Sep 3;18:1873893. doi: 10.3389/fnagi.2026.1873893. eCollection 2026.

Roles of lactate and protein lactylation in neurogenesis and neurodegenerative disease

Zhou X, Han J, Cui X, Wu S, Lu Z, Zong S.

J Transl Med. 2026 Sep 9;24(1):1210. doi: 10.1186/s12967-026-08940-2.

Are Signal Peptides Hidden Regulators of Neurodegenerative Disease?

Karbownik M, Fidura M, Perlikowska R.

Biomedicines. 2026 Aug 7;14(8):1781. doi: 10.3390/biomedicines14081781.

Targeting cellular senescence with Traditional Chinese Medicine: advances in neurodegenerative disorder treatment

Hai H, Li M, Hu X, Peng J, He Z.

Front Neurol. 2026 Aug 19;17:1875385. doi: 10.3389/fneur.2026.1875385. eCollection 2026.

Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy

Mohammad SI, Vasudevan A, Oriquat G, Gajjar TB, Hanumanthayya M, Shukla SK, Tailor NK, Baig MR, Fadaam O, Abdul AS.

Behav Brain Res. 2026 Sep 4;516:116455. doi: 10.1016/j.bbr.2026.116455. Online ahead of print.

From optical control to translational readiness: an evidence-tiered framework for optogenetics in neuromuscular and neurological disorders

Cao X, Liu Y, Ding M, Zhang C, Gao S, Chen H, Deng C.

Mater Today Bio. 2026 Sep 2;40:103643. doi: 10.1016/j.mtbio.2026.103643. eCollection 2026 Oct.

Astrocytes in Neurodegeneration: Spatial States, Crosstalk, and Emerging Therapies

Steger L, Rothhammer V, Zunke F.

Mol Neurobiol. 2026 Sep 14;63(1):893. doi: 10.1007/s12035-026-06142-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias